DOJ chief wades into dental antitrust case in rare intervention

The antitrust chief of the US Justice Department (DOJ) made a rare appearance in court when he requested that the US Court of Appeals for the Eleventh Circuit reject a defence used by a medical and dental board against an antitrust lawsuit.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Ukrainians plead guilty to trafficking counterfeit drugs into the US

20 July 2020 Two citizens of Ukraine have admitted to smuggling and distributing counterfeit cancer and hepatitis drugs into the US at the Southern District Court of Texas on July 17, according to the US Department of Justice.

Americas

DoJ weighs in on Amgen v Sandoz biosimilar clash

14 September 2017 The US Department of Justice (DoJ) has voiced its opinion on the biosimilar dispute between Amgen and Sandoz.

Americas

FTC and DoJ update antitrust guidelines

18 January 2017 The Federal Trade Commission and the Department of Justice have issued an update to the Antitrust Guidelines for Licensing of Intellectual Property, modernising the 1995 guidelines.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

DOJ chief wades into dental antitrust case in rare intervention

More on this story

Editor's picks

Editor's picks

More features